Estrogen Receptor Regulates E2F1 Expression to Mediate Tamoxifen Resistance

Molecular Cancer Research - United States
doi 10.1158/1541-7786.mcr-09-0395
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Nogo-B Receptor Increases the Resistance to Tamoxifen in Estrogen Receptor-Positive Breast Cancer Cells

Breast Cancer Research
Cancer ResearchOncology
2018English

MicroRNA-221/222 Negatively Regulates Estrogen Receptor Α and Is Associated With Tamoxifen Resistance in Breast Cancer.

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2016English

ERK/MAPK Regulates ERRγ Expression, Transcriptional Activity and Receptor-Mediated Tamoxifen Resistance in ER+ Breast Cancer

FEBS Journal
BiochemistryCell BiologyMolecular Biology
2014English

Sphingosine Kinase 1 Activation by Estrogen Receptor Α36 Contributes to Tamoxifen Resistance in Breast Cancer

Journal of Lipid Research
BiochemistryEndocrinologyCell Biology
2018English

Cezanne Regulates E2f1-Dependent HIF2 Expression

Journal of Cell Science
Cell Biology
2015English

Nuclear Myosin VI Regulates Estrogen Receptor Driven Gene Expression

Biophysical Journal
Biophysics
2019English

Discovery of Peptidomimetric Antagonists of Estrogen Receptor - Coactivator Interactions: A Novel Strategy to Combat Tamoxifen Drug Resistance

2001English

O-GlcNAcylation-Inducing Treatments Inhibit Estrogen Receptor Α Expression and Confer Resistance to 4-Oh-Tamoxifen in Human Breast Cancer-Derived McF-7 Cells

PLoS ONE
Multidisciplinary
2013English

Estrogen Receptor (ER ) Level but Not Its ER Cx Variant Helps to Predict Tamoxifen Resistance in Breast Cancer

Clinical Cancer Research
Cancer ResearchOncology
2004English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy